Mark A. Lovell

15.1k citations

109 papers · 12.4k indexed · 4 hit papers · h-index 56

Impact in

Biological Psychiatry top 0.5%
- Tryptophan and brain disorders
Physiology top 0.1%
- Alzheimer's disease research and treatments
- Biochemical effects in animals

Papers in

Physiology 56
- Alzheimer's disease research and treatments 55
Neurology 14

Co-authors: William R. Markesbery Chengsong Xie J. David Robertson W.J. Teesdale Jerry L. Campbell S. Prasad Gabbita Bert C. Lynn William D. Ehmann
Journals: Journal of Alzheimer s Disease (9 papers)Free Radical Biology and Medicine (8 papers)Journal of Neurochemistry (8 papers)Neurobiology of Aging (8 papers)Brain Research (5 papers)
Partner nations: United States Belgium Canada

In The Last Decade

Mark A. Lovell

107 papers receiving 12.1k citations

Hit Papers

align trajectories log scale

Copper, iron and zinc in Alzheimer's disease senile plaques 1998 · 1.8k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 Journal of the Neurological Sciences
1998 Neurobiology of Aging
1995 Journal of Neurochemistry
1995 Neurology

Peers

Countries citing papers authored by Mark A. Lovell

Since Specialization

Citations

This map shows the geographic impact of Mark A. Lovell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Lovell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Lovell more than expected).

Fields of papers citing papers by Mark A. Lovell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Lovell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Lovell. The network helps show where Mark A. Lovell may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Lovell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Lovell Line = papers co-authored together Mark A. Lovell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multiregional analysis of global 5‐methylcytosine and 5‐hydroxymethylcytosine throughout the progression of Alzheimer's disease Journal of Neurochemistry ·Zheng Hui, Erin L. Abner, Mark A. Lovell	2016	44
2	Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update Archives of Toxicology ·Melissa A. Bradley‐Whitman, Mark A. Lovell	2015	140
3	RNA Oxidation Adducts 8-OHG and 8-OHA Change with Aβ42 Levels in Late-Stage Alzheimer's Disease PLoS ONE ·Adam M. Weidner, R. S. A. Sorna Kumar, Tina L. Beckett, Dana M. Niedowicz, Amy L.S. Dowling, Sergey V. Matveev, Harry LeVine, Mark A. Lovell, M. Paul Murphy	2011	21
4	Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain Free Radical Biology and Medicine ·Oscar Rios Herrera, Shuling Xiong, Guo‐Min Li, Liya Gu, Guogen Mao, William R. Markesbery, Mark A. Lovell	2008	96
5	Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models Free Radical Biology and Medicine ·Joshua A. Sonnen, John C.S. Breitner, Mark A. Lovell, William R. Markesbery, Joseph F. Quinn, Thomas J. Montine	2008	87
6	Identification and characterization of OGG1 mutations in patients with Alzheimer's disease Nucleic Acids Research ·Guogen Mao, Xiaoyu Pan, Shunit Rinkevich, Yanbin Zhang, Fenghua Yuan, Jian Huang, Mark A. Lovell, Maxwell P. Lee, William R. Markesbery, Guo‐Min Li, Liya Gu	2007	100
7	Teratoid Wilms’ tumor, an important variant of nephroblastoma Journal of Pediatric Urology ·Jeremy B. Myers, S.M. KIM, Lorrie F. Odom, Loris McGavran, Mark A. Lovell, Peter Furness	2007	17
8	Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment Annals of Neurology ·William R. Markesbery, Richard J. Kryscio, Mark A. Lovell, Jason D. Morrow	2005	216
9	Quantitative Proteomic Analysis of Mitochondria from Primary Neuron Cultures Treated with Amyloid Beta Peptide Neurochemical Research ·Mark A. Lovell, Shuling Xiong, William R. Markesbery, Bert C. Lynn	2005	49
10	Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage alzheimer’s disease Neurotoxicity Research ·Mark A. Lovell, Jennifer L. Smith, Shuling Xiong, William R. Markesbery	2005	73
11	Intrinsic differences in brain and spinal cord mitochondria: Implication for therapeutic interventions The Journal of Comparative Neurology ·Patrick G. Sullivan, Alexander G. Rabchevsky, Jeffrey N. Keller, Mark A. Lovell, Rima Drizin, Ronald P. Hart, Stephen W. Scheff	2004	103
12	Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer’s disease Neurobiology of Aging ·Mark A. Lovell, J. David Robertson, Bruce A. Buchholz, Chengsong Xie, William R. Markesbery	2002	26
13	Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures Neurobiology of Aging ·Mark A. Lovell, Chengsong Xie, William R. Markesbery	2001	381
14	Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain Journal of Neurochemistry ·S. Prasad Gabbita, Michael Y. Aksenov, Mark A. Lovell, William R. Markesbery	1999	227
15	Idiopathic arterial calcification of infancy: sonographic and magnetic resonance findings with pathologic correlation Pediatric Radiology ·TrafficMuseumsAssociation, Gia A. DeAngelis, Mark A. Lovell, Klaus D. Hagspiel	1998	17
16	Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity Free Radical Biology and Medicine ·Chengsong Xie, Mark A. Lovell, William R. Markesbery	1998	62
17	4-Hydroxynonenal, a Product of Lipid Peroxidation, Damages Cholinergic Neurons and Impairs Visuospatial Memory in Rats Journal of Neuropathology & Experimental Neurology ·Annadora J. Bruce‐Keller, Yingjie Li, Mark A. Lovell, Philipp J. Kraemer, Devin S. Gary, 刘华鼐, William R. Markesbery, Mark P. Mattson	1998	107
18	Copper, iron and zinc in Alzheimer's disease senile plaques Journal of the Neurological Sciences ·Mark A. Lovell, J. David Robertson, W.J. Teesdale, Jerry L. Campbell, William R. Markesbery Hit paper breakdown →	1998	1799
19	Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study Journal of the Neurological Sciences ·Edward J. Kasarskis, Lav Tandon, Mark A. Lovell, William D. Ehmann	1995	122
20	Comparison of the effects of elevated intracellular aluminum and calcium levels on neuronal survival and tau immunoreactivity Brain Research ·Mark P. Mattson, Mark A. Lovell, William D. Ehmann, William R. Markesbery	1993	35

About Mark A. Lovell

Mark A. Lovell is a scholar working on Physiology, Neurology, Nutrition and Dietetics, Biological Psychiatry and Biochemistry, having authored 109 papers that have together received 12.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (55 papers), Trace Elements in Health (19 papers), Mitochondrial Function and Pathology (13 papers), Heavy Metal Exposure and Toxicity (13 papers), DNA Repair Mechanisms (12 papers), Folate and B Vitamins Research (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Aluminum toxicity and tolerance in plants and animals (8 papers). The work is most often cited by research in Biological Psychiatry (736 citations), Physiology (6.2k citations), Neurology (1.3k citations), Nutrition and Dietetics (2.3k citations) and Biochemistry (749 citations). Mark A. Lovell has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include William R. Markesbery, Chengsong Xie, J. David Robertson, W.J. Teesdale, Jerry L. Campbell, S. Prasad Gabbita, Bert C. Lynn, William D. Ehmann, Melissa A. Bradley‐Whitman and Shuling Xiong. Their work appears in journals such as Journal of Alzheimer s Disease, Free Radical Biology and Medicine, Journal of Neurochemistry, Neurobiology of Aging and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact